Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries

Catheterization and Cardiovascular Interventions

Volumn 81, Issue 5, 2013, Pages 793-799

  Wöhrle, Jochen ^a   Werner, Gerald S ^b  

^a UNIVERSITY OF ULM   (Germany)

^b KLINIKUM DARMSTADT   (Germany)

Author keywords

Chronic total occlusion; Paclitaxel; Restenosis; Stents

Indexed keywords

HEPARIN; PACLITAXEL; ANTITHROMBOCYTIC AGENT; BIOMATERIAL; CARDIOVASCULAR AGENT; METAL;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BALLOON OCCLUSION; BARE METAL STENT; BLOOD CLOT LYSIS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OCCLUSION; CORONARY ARTERY RECANALIZATION; CORONARY STENT; DEVICE SAFETY; DIABETES MELLITUS; DRUG ELUTING STENT; EQUIPMENT DESIGN; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; MALE; MATERIAL COATING; MULTICENTER STUDY; OCCLUSION BALLOON CATHETER; ANGIOCARDIOGRAPHY; CHI SQUARE DISTRIBUTION; CHRONIC DISEASE; DRUG COMBINATION; EQUIPMENT; GERMANY; HEART CATHETER; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; PROSTHESIS; RESTENOSIS; STENT; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIAC CATHETERS; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY OCCLUSION; CORONARY RESTENOSIS; DRUG THERAPY, COMBINATION; DRUG-ELUTING STENTS; EQUIPMENT DESIGN; FEMALE; GERMANY; HUMANS; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; PACLITAXEL; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84884184503     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24409     Document Type: Article

References (25)

1. Werner GS, Krack A, Schwarz G, Prochnau D, Betge S, Figulla HR. Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents. J Am Coll Cardiol 2004;44:2301-2306.
2. Suttorp MJ, Laarman GJ, Rahel BM, Kelder JC, Bosschaert MA, Kiemeneij F, Ten Berg JM, Bal ET, Rensing BJ, Eefting FD, Mast EG. Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): A randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions. Circulation 2006;114:921-928.
3. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Bohm M, Speck U. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2006;355:2113-2124.
4. Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, Werner GS, Antoni D, Kleber FX, Bocksch W, Leschke M, Ackermann H, Boxberger M, Speck U, Degenhardt R, Scheller B. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary instent restenosis. Circulation 2009;119:2986-2994.
5. Unverdorben M, Kleber FX, Heuer H, Figulla HR, Vallbracht C, Leschke M, Cremers B, Hardt S, Buerke M, Ackermann H, Boxberger M, Degenhardt R, Scheller B. Treatment of small coronary arteries with a paclitaxel-coated balloon catheter. Clin Res Cardiol 2010;99:165-174.
6. Wohrle J, Birkemeyer R, Markovic S, Nguyen TV, Sinha A, Miljak T, Spiess J, Rottbauer W, Rittger H. Prospective randomised trial evaluating a paclitaxel-coated balloon in patients treated with endothelial progenitor cell capturing stents for de novo coronary artery disease. Heart 2011;97:1338-1342.
7. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME;TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-231.
8. Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, O'Shaughnessy CD, DeMaio S, Hall P, Popma JJ, Koglin J, Russell ME;TAXUS V Investigators. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: A randomized controlled trial. JAMA 2005;294:1215-1223.
9. Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R. Vascular responses to drug eluting stents: Importance of delayed healing. Arterioscler Thromb Vasc Biol 2007;27:1500-1510.
10. Hwang CW, Wu D, Edelman ER. Physiological transport forces govern drug distribution for stent-based delivery. Circulation 2001;104:600-605.
11. Werner GS, Ferrari M, Fritzenwanger M, Betge S, Figulla HR. Long-term safety and efficacy of paclitaxel-eluting stents in chronic total coronary occlusions: 3 year follow-up from the paclitaxel in chronic total occlusion (PACTO) study. Eur Heart J 2007;28 (Abstract):135.
12. Mathey DG, Wendig I, Boxberger M, Bonaventura K, Kleber FX. Treatment of bifurcation lesions with a drug-eluting balloon: The PEPCAD V (Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease) trial. EuroIntervention 2011;7(Suppl K):K61-K65.
13. Di Mario C, Werner GS, Sianos G, Galassi AR, Buttner J, Dudek D, Chevalier B, Lefevre T, Schofer J, Koolen J, Sievert H, Reimers B, Fajadet J, Colombo A, Gershlick A, Serruys PW, Reifart N. European perspective in the recanalisation of chronic total occlusions 8CTO): Consensus document from the Euro- CTO Club. EuroInterv 2007;3:30-43.
14. Herdeg C, Gohring-Frischholz K, Haase KK, Geisler T, Zurn C, Hartmann U, Wohrle J, Nusser T, Dippon J, May AE, Gawaz M. Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation. Circ Cardiovasc Interv 2009;2:294-301.
15. Wohrle J, Nusser T, Hoffmann S, Kochs M. Angiographic results of the cobalt chromium Vision and Mini-Vision stents. Can J Cardiol 2009;25:581-584.
16. Wohrle J, Rottbauer W, Imhof A. Everolimus-eluting stents for treatment of chronic total coronary occlusions. Clin Res Cardiol 2012;101:23-28.
17. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, Pichard AD, Kent KM, Stone GW, Leon MB. Angiographic patterns of in-stent restenosis: Classification and implications for long-term outcome. Circulation 1999;100:1872-1878.
18. Werner GS, Schwarz G, Prochnau D, Fritzenwanger M, Krack A, Betge S, Figulla HR. Paclitaxel-eluting stents for the treatment of chronic total coronary occlusions: A strategy of extensive lesion coverage with drug-eluting stents. Catheter Cardiovasc Interv 2006;67:1-9.
19. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW;Academic Research Consortium. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007;115:2344-2351.
20. Rubartelli P, Petronio AS, Guiducci V, Sganzerla P, Bolognese L, Galli M, Sheiban I, Chirillo F, Ramondo A, Bellotti S;Gruppo Italiano di Studio sullo Stent nelle Occlusioni Coronariche II GISE Investigators. Comparison of sirolimus-eluting and bare metal stent for treatment of patients with total coronary occlusions: Results of the GISSOC II-GISE multicentre randomized trial. Eur Heart J 2010;31:2014-2020.
21. Stone GW, Rizvi A, Newman W, Mastali K, Wang JC, Caputo R, Doostzadeh J, Cao S, Simonton CA, Sudhir K, Lansky AJ, Cutlip DE, Kereiakes DJ;SPIRIT IV Investigators. Everolimuseluting versus paclitaxel-eluting stents in coronary artery disease. N Engl J Med 2010;362:1663-1674.
22. Kedhi E, Joesoef KS, McFadden E, Wassing J, van Mieghem C, Goedhart D, Smits PC. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): A randomised trial. Lancet 2010;375:201-209.
23. Ge L, Iakovou I, Cosgrave J, Chieffo A, Montorfano M, Michev I, Airoldi F, Carlino M, Melzi G, Sangiorgi GM, Corvaja N, Colombo A. Immediate and mid-term outcomes of sirolimus- eluting stent implantation for chronic total occlusions. Eur Heart J 2005;26:1056-1062.
24. Nakamura S, Muthusamy TS, Bae JH, Cahyadi YH, Udayachalerm W, Tresukosol D. Impact of sirolimus-eluting stent on the outcome of patients with chronic total occlusions. Am J Cardiol 2005;95:161-166.
25. Colmenarez HJ, Escaned J, Fernández C, Lobo L, Cano S, del Angel JG, Alfonso F, Jimenez P, Banuelos C, Gonzalo N, Garci'a E, Hernández R, Macaya C. Efficacy and safety of drug-eluting stents in chronic total coronary occlusion recanalization: A systematic review and meta-analysis. J Am Coll Cardiol 2010;55:1854-1866.